VAERS reports by lot

GSK DTaP/Tdap lot 5H773: VAERS reports

28 VAERS reports list lot 5H773 as a GSK DTaP/Tdap vaccine, received between 2023-11-29 and 2025-10-10. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction880%
Gastrointestinal110%
Dermatological (non-injection-site)110%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan5
Arizona5
California3
Texas2
South Carolina2
Arkansas2
Illinois2
Georgia1
Indiana1
Kansas1
Wisconsin1
Maryland1

Reports by month received

MonthReportsBar
2023-112
2023-121
2024-012
2024-024
2024-031
2024-045
2024-051
2024-061
2024-071
2025-011
2025-031
2025-061
2025-071
2025-083
2025-092
2025-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): 594SR · 5AY2J · 5G23D · 5H95B · 5KR3R · 5YB5G

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.